One Stop Shop for All Your Market Research Reports

Opioid Use Disorder Market - Global Outlook and Forecast 2022-2028

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress. This report contains market size and forecasts of Opioid Use Disorder in Global, including the following market information: Global Opioid Use Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Opioid Use Disorder market was valued at 1798.3 million in 2021 and is projected to reach US$ 2608.2 million by 2028, at a CAGR of 5.5% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Buprenorphine Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Opioid Use Disorder include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus and Omeros. etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Use Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Opioid Use Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Opioid Use Disorder Market Segment Percentages, by Type, 2021 (%) Buprenorphine Methadone Naltrexone Global Opioid Use Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Opioid Use Disorder Market Segment Percentages, by Application, 2021 (%) Moderate Pain Treatment Severe Pain Treatment Global Opioid Use Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Opioid Use Disorder Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Opioid Use Disorder revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Opioid Use Disorder revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Indivior Alkermes Titan Pharmaceuticals Hikma Pharmaceuticals Teva Pharmaceuticals MediciNova Orexo Camurus Omeros
1 Introduction to Research & Analysis Reports 1.1 Opioid Use Disorder Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Opioid Use Disorder Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 926452
Category
  • Healthcare
Published on 06-May
Number of Pages 70
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(26)